| |
|
Presenting author |
# |
Title |
 |
|
| |
 |
Stevenson, Emma |
P1 |
MULTIPLE RELAPSES WITH CO-INFECTION OF TWO Clostridium difficile RIBOTYPES- A CASE STUDY |
|
|
| |
|
Matsumoto, Asami |
P2 |
COMPARISON OF CLINICAL SEVERITY, GENOTYPE AND TOXIN GENE EXPRESSION OF BINARY TOXIN-PRODUCIND Clostridium difficile CLINICAL ISOLETES IN JAPAN |
|
|
| |
|
Moorhead, Sian |
P3 |
SYNGERGISTIC EFFICACY OF 405 NM LIGHT AND HOSPITAL DISINFECTANTS FOR THE ENHANCED DECONTAMINATION OF C. difficile ON CLINICALLY RELEVANT SURFACES |
|
|
| |
|
Murabata, Mayumi |
P4 |
ENVIRONMENTAL CONTAMINATION OF Clostridium difficile IN THE PEDIATRIC WARD OF A HOSPITAL IN JAPAN |
|
|
| |
|
Lawry, Beth |
P5 |
CHARACTERISING DIAGNOSTIC BIOMARKERS FOR Clostridium difficile |
|
|
| |
|
Pai, Hyunjoo |
P6 |
CLINICAL CHARACTERISTICS OF Clostridium difficile RIBOTYPE 017 AND 018 INFECTIONS |
|
|
| |
|
Miyajima, Fabio |
P7 |
PREDICTING POOR DISEASE OUTCOMES OF Clostridium difficile INFECTION: THE QUEST FOR MORE ANSWERS? |
|
|
| |
|
Lister, Michelle |
P8 |
PREVALENCE OF PATIENTS INFECTED WITH MULTIPLE Clostridium difficile RIBOTYPES AT THE UNIVERSITY OF NOTTINGHAM HOSPITALS TRUST 2013/14. IS THIS A PRECURSOR FOR RELAPSE? |
|
|
| |
|
Reigadas, Elena |
P9 |
CLINICAL SIGNIFICANCE OF CYTOTOXICITY AND TOXIGENIC CULTURE IN C. difficile INFECTION |
|
|
| |
|
Hell, Markus |
P10 |
CLINICAL EVALUATION OF A NOVEL Clostridium difficile MOLECULAR ONE STEP TEST SYSTEM |
|
|
| |
|
Roberts, Paul |
P11 |
TOXIGENICITY OF Clostridium difficile STRAINS ISOLATED FROM GDH-POSITIVE FAECAL SAMPLES |
|
|
| |
|
Alcalá, Luis |
P12 |
COMPARISON OF TWO MULTI-STEP ALGORITHMS FOR DIAGNOSIS OF Clostridium difficile INFECTION |
|
|
| |
|
Banz, Alice |
P13 |
DEVELOPMENT OF AN ULTRA-SENSITIVE Clostridium difficile TOXINS A AND B ASSAY USING A DIGITAL TECHNOLOGY |
|
|
| |
|
Casari, Erminia |
P14 |
THE IMPLEMENTATION OF A RT-PCR STANDALONE TEST MAINTAINS STABLE THE NUMBER OF Clostridium difficile INFECTION EPISODES IN A TERTIARY RESEARCH HOSPITAL |
|
|
| |
|
Kirveskari , Juha |
P15 |
DIFFERENTIATING VIRULENT 027 AND NON-027 C. difficile BY MOLECULAR METHODS |
|
|
| |
|
Matero, Pirjo |
P16 |
A MULTI-CENTRE PERFORMANCE EVALUATION STUDY OF THE ORION GENREAD® C. difficile TEST |
|
|
| |
|
Longshaw, Chris |
P17 |
THE IMPACT OF THE INTRODUCTION OF FIDAXOMICIN ON THE MANAGEMENT OF Clostridium difficile INFECTION IN 7 NHS SECONDARY CARE TRUSTS IN ENGLAND |
|
|
| |
|
Lombardo, Mary-Jane |
P18 |
SER-109, AN ORAL THERAPEUTIC COMPOSED OF BACTERIAL SPORES, CATALYZED DIVERSIFICATION OF THE GUT MICROBIOTA AND PREVENTION OF RECURRENT Clostridium difficile INFECTION |
|
|
| |
|
Hell, Markus |
P19 |
HIGH PREVALENCE OF BINARY TOXIN PRODUCING Clostridium difficile AMONG HOSPITALIZED SYMPTOMATIC PATIENTS IN WESTERN AUSTRIA 2014 |
|
|
| |
|
Rupnik, Maja |
P20 |
C. difficile INFECTION IN SLOVENIAN HOSPITALS – A POINT PREVALENCE STUDY |
|
|
| |
|
Di Bella, Stefano |
P21 |
Clostridium difficile INFECTION AMONG HOSPITALIZED HIV-INFECTED INDIVIDUALS IN ITALY: EPIDEMIOLOGY AND RISK FACTORS (2002-2013) |
|
|
| |
|
Goswami, Cosmika |
P22 |
UNDERSTANDING MOLECULAR EPIDEMIOLOGY OF Clostridium difficile IN SCOTLAND |
|
|
| |
|
Hong, Hsueh-En |
P23 |
EMERGING Clostridium difficile PCR RIBOTYPE 251 INFECTION IN WESTERN AUSTRALIA |
|
|
| |
|
Ito, Yoichiro |
P24 |
MOLECULAR EPIDEMIOLOGY OF Clostridium difficile AT A HOSPITAL IN JAPAN: SHIFTS IN THE PREDOMINANT PCR RIBOTYPE OVER A NINE-YEAR PERIOD |
|
|
| |
|
Kato, Haru |
P25 |
PREVALENCE OF TWO PCR RIBOTYPES, SMZ (018) AND TRF (369) OF Clostridium difficile IN JAPAN |
|
|
| |
|
Niwa, Hidekazu |
P26 |
GENOTYPE TRANSITION OF Clostridium difficile AT A THOROUGHBRED RACEHORSE CLINIC IN JAPAN FROM 2010– 2014 |
|
|
| |
|
Kim, Heejung |
P27 |
DIAGNOSTIC PERFORMANCE OF Clostridium difficile INFECTION AND C. difficile EPIDEMIOLOGY IN A TERTIARY CARE HOSPITAL IN SOUTH KOREA IN 2014 |
|
|
| |
|
Pai, Hyunjoo |
P28 |
CLONALITY OF Clostridium difficile PCR RIBOTYPE 018 STRAINS IN A TERTIARY HOSPITAL ANALYZED BY MLVA (MULTILOCUS VARIABLE-NUMBER TANDEM REPEAT ANALYSIS) |
|
|
| |
|
Pavic, Sladjana |
P29 |
MONITORING OF Clostridium difficile INFECTIONS IN REGION OF WESTERN SERBIA |
|
|
| |
|
Jovanović, Milica |
P30 |
Clostridium difficile AT TWO HEALTH INSTITUTIONS IN BELGRADE - INCREASING AWARENESS OF THE INFECTION |
|
|
| |
|
Trajkovska-Dokic, Elena |
P31 |
TOXIGENIC Clostridium difficile STRAINS IN HOSPITALIZED PATIENTS |
|
|
| |
|
Rodriguez, Cristina |
P32 |
CARRIAGE OF Clostridium difficile IN HOSPITAL PATIENTS IN SPAIN, INCLUDING MOLECULAR CHARACTERIZATION, ANTIMICROBIAL SUSCEPTIBILITY AND MULTILOCUS SEQUENCE TYPING COMPARAISON WITH BELGIAN BACTERIAL ISOLATES |
|
|
| |
|
Van Broeck, Johan |
P33 |
DISTRIBUTION OF RIBOTYPES OF Clostridium difficile IN A BELGIAN UNIVERSITY HOSPITAL : SURVEILLANCE DATA 2011-2014 |
|
|
| |
|
Van Broeck, Johan |
P34 |
DISTRIBUTION OF RIBOTYPES OF Clostridium difficile IN BELGIAN ACUTE HOSPITALS : SURVEILLANCE DATA 2009-2013 |
|
|
| |
|
Neely, Fiona |
P35 |
SURVEILLANCE OF Clostridium difficile INFECTION IN BELGIAN HOSPITALS 2013: DIVERSITY OF RIBOTYPES AND HIGHEST INCIDENCE SINCE 2009 |
|
|
| |
|
Stein, Katharina |
P36 |
ANALYSIS OF THE EPIDEMIOLOGY OF Clostridium difficile INFECTION IN IRELAND 2014 |
|
|
| |
|
Carman, Robert |
P37 |
Clostridium difficile RIBOTYPES IN SOUTH WESTERN VIRGINIA 2007-2014: FITNESS AND VIRULENCE |
|
|
| |
|
Golding, George |
P38 |
MOLECULAR AND EPIDEMIOLOGICAL CHARACTERIZATION OF HEALTHCARE-ASSOCIATED Clostridium difficile INFECTIONS 2007-2013, CANADA |
|
|
| |
|
Collins, Deirdre |
P39 |
MONITORING AND EXAMINATION OF Clostridium difficile TESTING REQUESTS IN WESTERN AUSTRALIA |
|
|
| |
|
Garneau, Julian |
P40 |
RELATIONSHIP BETWEEN MLVA GENETIC TYPES AND CLINICAL OUTCOMES FOLLOWING INFECTION BY Clostridium difficile RIBOTYPE 027 |
|
|
| |
|
Androga, Grace |
P41 |
CO-INFECTION INVOLVING TOXIN A-NEGATIVE, TOXIN B-NEGATIVE, BINARY TOXIN-POSITIVE Clostridium difficile |
|
|
| |
|
Mallia, Gabriella |
P42 |
EVALUATION OF THE EPIDEMIOLOGY AND MICROBIOLOGY OF Clostridium difficile IN LONG TERM CARE FACILITY RESIDENTS |
|
|
| |
|
Beigot Glaser, Sara |
P43 |
METHODS FOR Clostridium difficile ISOLATION FROM ENVIRONMENTAL SAMPLES |
|
|
| |
|
Janezic, Sandra |
P44 |
STABLE TREND OF OVERLAPPING Clostridium difficile PCR-RIBOTYPES BETWEEN HUMAN, ANIMAL AND ENVIRONMENTAL ISLATES IN SLOVENIA, DURING 2008-2014 |
|
|
| |
|
Andrés-Lasheras, Sara |
P45 |
CARRIAGE OF Clostridium difficile BY WILD ANIMAL SPECIES RELATED TO PIG FARMS IN SPAIN |
|
|
| |
|
Avberšek, Jana |
P46 |
Clostridium difficile IN ANIMALS IN SLOVENIA : AN OVERVIEW FOR YEARS 2005 – 2014 |
|
|
| |
|
Corver, Jeroen |
P47 |
WHOLE GENOME SEQUENCING REVEALS POTENTIAL SPREAD OF Clostridium difficile BETWEEN HUMANS AND FARM ANIMALS IN THE NETHERLANDS, 2002 TO 2011 |
|
|
| |
|
Elliott, Briony |
P48 |
COMPARATIVE GENOMICS AND ANTIMICROBIAL SUSCEPTIBILITY OF Clostridium difficile PCR RIBOTYPE 014 ISOLATED FROM HUMANS AND PIGLETS IN AUSTRALIA |
|
|
| |
|
Garcia, Marta E. |
P49 |
ISOLATION OF Clostridium difficile FROM DOGS IN A VETERINARY CLINICAL HOSPITAL |
|
|
| |
|
Ocepek, Matjaž |
P50 |
ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF Clostridium difficile ISOLATES FROM FAMILY DAIRY FARMS |
|
|
| |
|
Moono, Peter |
P51 |
PERSISTENCE OF Clostridium difficile PCR RIBOTYPE 237 IN A WESTERN AUSTRALIAN COMMERCIAL PIGGERY |
|
|
| |
|
Norman, Keri |
P52 |
USE OF NEXT GENERATION SEQUENCING TO EXPLORE THE DIVERSITY OF TOXINOTYPE V STRAINS ORIGINATING FROM A CLOSED POPULATION OF HUMANS AND SWINE |
|
|
| |
|
Usui, Masaru |
P53 |
DISTRIBUTION AND CHARACTERIZATION OF C. difficile DERIVED FROM DOGS IN JAPAN, AND THEIR RISK ASSOCIATED WITH HUMAN HEALTH |
|
|
| |
|
Blanco, Jose L. |
P54 |
METRONIDAZOLE (HETERO)RESISTANT Clostridium difficile ISOLATES OF ANIMAL ORIGIN: AN OVERVIEW FROM SPAIN |
|
|
| |
|
Lim, Su-Chen |
P55 |
SUSCEPTIBILITY OF Clostridium difficile TO FOOD PRESERVATIVES SODIUM METABISULPHITE, SODIUM NITRATE AND SODIUM NITRITE |
|
|
| |
|
Wang, Qiong |
P56 |
THE DEVELOPMENT OF A NOVEL C. difficile LYSIN TO CONTROL C. difficile INFECTION IN A MURINE MODEL |
|
|
| |
|
Arnaud-Barbe, Nadège |
P57 |
SEQUENCE CONSERVATION AND VARIABILITY OF C.DIFFICILE TOXINS TcdA AND TcdB FROM PREVALENT VARIANT STRAINS AS COMPARED TO REFERENCE STRAIN USED IN SANOFI PASTEUR'S Clostridium difficile TOXOID VACCINE |
|
|
| |
|
Anosova, Natalie |
P58 |
COCKTAIL OF FULLY HUMAN RECOMBINANT MONOCLONAL ANTIBODIES AGAINST Clostridium difficile ASSOCIATED DISEASE |
|
|
| |
|
Fühner, Viola |
P59 |
DEVELPOMENT OF ANTIBODIES TARGETING TcdA AND TcdB OF Clostiridium difficile |
|
|
| |
|
Hutton, Melanie |
P60 |
BOVINE COLOSTRUM ANTIBODIES FOR THE PREVENTION AND TREATMENT OF C. difficile INFECTION AND DISEASE |
|
|
| |
|
Batah, Jameel |
P61 |
Clostridium difficile FLAGELLIN FLIC PREDOMINANTLY ACTIVATES TLR5-LINKED NF-KB PATHWAY IN EPITHELIAL CELLS |
|
|
| |
|
Batah, Jameel |
P62 |
C. difficile FLAGELLA INDUCE A PRO-INFLAMMATORY RESPONSE IN INTESTINAL EPITHELIUM IN SYNERGY WITH TOXINS TCDA AND TCDB IN A CDI MOUSE MODEL. |
|
|
| |
|
Lees, Emily |
P63 |
CHARACTERISATION OF CIRCULATING Clostridium difficile STRAINS AND MUCOSAL INFLAMMATORY RESPONSE IN CHILDREN WITH DIARRHOEA IN MERSEYSIDE, UK |
|
|
| |
|
Patel, Dhaval |
P64 |
COMPARISON OF TOXIN NEUTRALIZATION ASSAYS (TNA) FOR QUANTIFICATION OF C. difficile TOXIN A and B SPECIFIC NEUTRALIZING ANTIBODIES IN HUMAN SERUM |
|
|
| |
|
Janoir, Claire |
P65 |
IMMUNOGENIC PROPERTIES OF THE SURFACE LAYER PROTEIN (SLPA) OF Clostridium difficile AND IMMUNIZATION ASSAYS IN ANIMAL MODELS |
|
|
| |
|
Monaghan, Tanya |
P66 |
PROFILING HUMORAL IMMUNE RESPONSES TO C. difficile-SPECIFIC ANTIGENS BY PROTEIN MICROARRAY |
|
|
| |
|
Monaghan, Tanya |
P67 |
EFFECTS OF BOVINE LACTOFERRIN IN AN IN VITRO HUMAN GUT MODEL OF C. difficile INFECTION |
|
|
| |
|
Gerhard, Ralf |
P68 |
THE GLUCOSYLTRANSFERASE OF TOXIN B ACTIVATES NEUTROPHILS |
|
|
| |
|
Therien, Alex |
P69 |
MECHANISMS OF PROTECTION BY THE ANTITOXIN ANTIBODIES ACTOXUMAB AND BEZLOTOXUMAB IN RODENT MODELS OF Clostridium difficile INFECTION |
|
|
| |
|
Peng, Yibing |
P70 |
INSIGHT INTO ALTERATION OF GUT MICROBIOTA IN C. difficile INFECTION AND ASYMPTOMATIC C. difficile COLONIZATION |
|
|
| |
|
Jukes, Caitlin |
P71 |
THE IMPACT OF BILE ACID MODIFICATION ON Clostridium difficile COLONISATION |
|
|
| |
|
Mahnic, Aleksander |
P72 |
EFFECT OF C. difficile SPENT MEDIUM ON FECAL MICRIOBIOTA COMMUNITY STRUCTURE IN A SIMPLE IN VITRO MODEL |
|
|
| |
|
Yuille, Samantha |
P73 |
UNDERSTANDING GUT INSTINCT: OPTIMISING GUT COLONISATION RESISTANCE AGAINST Clostridium difficile INFECTION |
|
|
| |
|
Janezic, Sandra |
P74 |
COMPARATIVE GENOMICS OF Clostridium difficile TOXINOTYPES |
|
|
| |
|
Keseler, Ingrid |
P75 |
A MODEL-ORGANISM DATABASE FOR Clostridium difficile 630 |
|
|
| |
|
Slater, Ross |
P76 |
CHARACTERIZATION OF LuxS DEPENDENT BIOFILM FORMATION BY Clostridium difficile |
|
|
| |
|
Poquet, Isabelle |
P77 |
GENOME WIDE ANALYSIS OF GENE EXPRESSION IN Clostridium difficile BIOFILMS |
|
|
| |
|
Kint, Nicolas |
P78 |
THE SIGMA FACTOR, SigB, CONTROLS SURVIVAL IN STATIONARY PHASE, SPORULATION, MOTILITY AND METABOLISM IN Clostridium difficile |
|
|
| |
|
Dembek, Marcin |
P79 |
HIGH-THROUGHPUT ANALYSIS OF SPORULATION-RELATED GENES IN Clostridium difficile R20291 |
|
|
| |
|
Nawrocki, Kathryn |
P80 |
CODY-DEPENDENT REGULATION OF SPORULATION INITIATION IN Clostridium difficile |
|
|
| |
|
Kirby, Jonathan |
P81 |
THE STRUCTURE OF CWP84, A CYSTEINE PROTEASE REQUIRED FOR THE MATURATION OF THE S-LAYER OF Clostridium difficile |
|
|
| |
|
Passmore, Ian |
P82 |
DISASSEMBLY OF BACTERIAL BIOFILMS |
|
|
| |
|
Pich, Andreas |
P83 |
THE PROTEOME OF HUMAN CELLS IS ALTERED BY TOXINS A AND B OF Clostridium difficile |
|
|
| |
|
Buckley, Anthony |
P84 |
BIOFILM FORMATION IN Clostridium difficile |
|
|
| |
|
Corver, Jeroen |
P85 |
THE HTRA-LIKE PROTEASE CD3284 MODULATES VIRULENCE OF Clostridium difficile |
| |
|
Couchman, Edward |
P86 |
TYPE IV PILI OF Clostridium difficile |
|
|
| |
|
Crawshaw, Adam |
P87 |
STRUCTURAL STUDIES OF TYPE IV PILI PROTEINS IN Clostridium difficile |
|
|
| |
|
Montfort-Gardeazabal, Jorge M. |
P88 |
THE ROLE OF THE AGR LOCUS IN THE EXPRESSION OF VIRULENCE FACTORS IN Clostridium difficile |
|
|
| |
|
Richards, Emma |
P89 |
INVESTIGATION OF A NOVEL, PUTATIVE S-LAYER GLYCOSYLATION CLUSTER IN Clostridium difficile |
|
|
| |
|
Shaw, H. Alexandra |
P90 |
CONTROL OF SURFACE PROTEINS IN C. difficile |
|
|
| |
|
Therien, Alex |
P91 |
NOVEL CELL-BASED ASSAYS MEASURING EARLY AND LATE EFFECTS OF Clostridium difficile TOXINS |
|
|
| |
|
Anwar, Saba |
P92 |
ROLE OF ADHESION IN Clostridium difficile INFECTION |
|
|
| |
|
Armstrong, Glen |
P93 |
ROLE OF TYPE 4 PILI IN THE Clostridium difficile PATHOGENIC PROGRAM |
|
|
| |
|
Collignon, Anne |
P94 |
VARIABILITY OF BIOFILMS FORMED IN VITRO BY Clostridium difficile STRAINS |
|
|
| |
|
Janoir, Claire |
P95 |
SPATIAL ORGANIZATION OF TISSUE-ASSOCIATED BACTERIA IN A Clostridium difficile MONOXENIC MOUSE MODEL |
|
|
